Navigation Links
Manchester College Receives $35 Million Grant From Lilly Endowment for School of Pharmacy
Date:12/20/2010

FORT WAYNE, Ind., Dec. 20, 2010 /PRNewswire/ -- A small Midwest college that is producing alumni with sizeable reputations in the science world has received a $35 million grant from Lilly Endowment to launch a School of Pharmacy.

Manchester College, located in northern Indiana, has a Nobel Laureate in chemistry, the inventor of Teflon®, the discoverer of acid rain in North America and the first female commissioner of the U.S. Food and Drug Administration among its graduates.

The grant – the largest in Manchester College history – will help the liberal arts and sciences college develop its first doctoral program on a Fort Wayne campus, surrounded by regional hospitals, pharmacies and health care facilities and services.

Speaking on behalf of Lilly Endowment, Sara B. Cobb, vice president of education, said, "We are pleased to offer this funding to Manchester College to assist it in establishing its new School of Pharmacy. The school will further important efforts in Indiana to increase opportunities for education and careers in the STEM (science, technology, engineering, mathematics) disciplines. The Endowment believes this support should add significantly to the intellectual capital in Northeast Indiana and enhance the vibrant life sciences sector growing throughout the state."

Responding to the national shortage of pharmacists and openings in pharmacy schools, Manchester announced last fall its plans to seek accreditation for a four-year doctoral program in pharmacy, with the first classes beginning in fall 2012.

"Lilly Endowment is making a powerful impact on the college's ability to focus on the most important work before us: building a distinctive, academically strong, mission-centered School of Pharmacy," said President Jo Young Switzer.

"This grant enhances our tools to attract exceptional faculty in a highly competitive market," said Switzer. "When accredited, the School of Pharmacy will enroll
'/>"/>

SOURCE Manchester College
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
2. Manchester Announces Availability of Chenodal(TM)
3. NicOx Naproxcinod Phase 3 Results Presented at American College of Rheumatology
4. YouthAIDS, Levis and BETs Rap It-Up Campaign Kick Off 2007 Kick Me Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country
5. Trojan(R) and the National Sexuality Resource Centers Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health
6. Clinical Impact of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) is Subject of Symposium at 16th Annual Scientific Congress of Hong Kong College of Cardiology
7. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
8. Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
9. American College of Cardiology and Center of Excellence for Simulation Research of Western Michigan University (CESR) Partner for in situ Simulation to Improve Team Communication and Door-to-Balloon (D2B) Time
10. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
11. Quality Colonoscopy Exam Remains Best Strategy for Detection of Polyps and Cancers According to Experts From the American College of Gastroenterology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , Sept. 1, 2015  Edwards Lifesciences Corporation ... science of heart valves and hemodynamic monitoring, is scheduled ... Conference at the Hyatt Regency Boston in ... Michael A. Mussallem , Edwards Lifesciences, ... speaker followed by a company discussion with conference attendees ...
(Date:9/1/2015)... Belgium , Sept. 1, 2015 VolitionRx ... on developing blood-based diagnostic tests for a broad range of ... Executive Officer, Cameron Reynolds , is scheduled to attend ... is being held September 9-10, 2015 in Boston, ... on September 10. Wells Fargo Securities Research ...
(Date:9/1/2015)... 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that Steven ... and David Haen , Vice President of ... corporate overview at two significant investment conferences in ... industries: the FBR & Co. Second Annual Health ...
Breaking Medicine Technology:VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 2VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 3VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 4CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4
... Inc., a medical device development company, today announced the ... (POC) with Auto Mode technology. ... only 4.9 pounds, the LifeChoice POC with Auto Mode ... detect and adjust patient therapy based on oxygen requirements ...
... 2011 OrbusNeich today announced that the company,s Genous ... vessel compared with bare metal stents and drug eluting ... presented by Ladislav Groch, M.D., of the University Hospital ... Research II session at Transcatheter Cardiovascular Therapeutics (TCT) 2011 ...
Cached Medicine Technology:Inova Labs Announces Launch of the LifeChoice Portable Oxygen Concentrator With Auto Mode Technology 2OrbusNeich's Genous™ Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation 2OrbusNeich's Genous™ Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation 3
(Date:9/2/2015)... NV (PRWEB) , ... September 02, 2015 , ... ... and Fort Lauderdale, CENTURION SERVICE GROUP is internationally known as an industry leader ... auction house in the world, selling more than 100,000 pieces of medical equipment ...
(Date:9/2/2015)... ... September 02, 2015 , ... “ G-Hold ” was featured on ... technology products available to consumers. Amanda Forstrom, a technology expert and special reporter for ... people to comfortably hold a tablet while reducing the likelihood of it dropping. , ...
(Date:9/2/2015)... ... September 02, 2015 , ... Canopy Partners, ... named to the Inc. 5000 List, an independent ranking of the fastest- ... 34 years, and this achievement puts Canopy in rarefied company. Over the years, ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... for the telling the truth about medicine and health, truths that other doctors ... blog, where he plans to regularly debunk certain misconceptions surrounding cholesterol, metabolically directed ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... (FDA) for the treatment of androgenic alopecia in adults, announces Miami-based medical device ... therapy cap, while also demonstrating its safety when used at home to combat ...
Breaking Medicine News(10 mins):Health News:Over 1800 Lots of Surplus Used Medical Equipment 2Health News:Over 1800 Lots of Surplus Used Medical Equipment 3Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2Health News:Dr. Michael Rothman, NJ’s Leading Holistic Doctor, Presents a Video Blog that Discusses the Most Confusing and Interesting Current Medical Topics 2Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2
... ... ... ... ...
... ... ... ... ...
... ... ... , ... , , , ...
... in the March edition of the Journal of ... patient,s outlook as it relates to health behavior and ... discovered that those who exhibited an optimistic disposition experienced ... Previous research into how the body communicates ...
... for advanced endoscopic procedures with a low rate of ... according to a new study in Clinical Gastroenterology ... Gastroenterological Association (AGA) Institute. "This is the ... (AMs) associated with propofol use in endoscopy. We believe ...
... ... objective of the PACT program is to continue to advance cellular ... and biologic systems, and targeted treatments for serious diseases without effective ... research in novel cell therapies, to advance the field of cellular ...
Cached Medicine News:Health News:The First Annual CQ HealthBeat Conference 2Health News:The First Annual CQ HealthBeat Conference 3Health News:The First Annual CQ HealthBeat Conference 4Health News:The First Annual CQ HealthBeat Conference 5Health News:Battling a Biceps Injury 2Health News:Battling a Biceps Injury 3Health News:Battling a Biceps Injury 4Health News:Battling a Biceps Injury 5Health News:Battling a Biceps Injury 6Health News:Battling a Biceps Injury 7Health News:AUA Foundation Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 2Health News:AUA Foundation Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 3Health News:Lung cancer research explores the effects of patient attitudes on patient outcomes 2Health News:Adverse events rate is low when propofol is administered by trained professional 2Health News:NIH/NHLBI-funded PACT Group Announces the Renewal of Production Assistance for Cellular Therapies (PACT) 2Health News:NIH/NHLBI-funded PACT Group Announces the Renewal of Production Assistance for Cellular Therapies (PACT) 3
... One device provides both low ... a single gas source , Reduce ... number of SKUs dedicated to nebulizers ... of double or wye set ups ...
... achieves optimum lung penetration for maximum therapeutic ... 1.04-1.10 µ at 6-8 LPM. Latex-free components. ... ,As the world leader in airway management ... of proven technology by offering top brands ...
... is improved CNBT technology, which relieves the practitioner ... 15 minutes. HOPE allows you the ability to ... administration couldn't be easier, with a length of ... can turn the HOPE nebulizer into an inexpensive ...
... Thera-Mist® Air Entrainment Nebulizers deliver particulate humidity ... for your chronic secretion patients. For your ... your existing supply of sterile water., ... at FiO2's of 20-50% with a total ...
Medicine Products: